Cellular Immune Defense & mRNA Antigen Simulator

Lipid Nanoparticle (LNP)

Live Virion

mRNA / Ribosome Translation

MHC-I Surface Complex

Cytotoxic T-Cell (CD8+)

Pathway Mechanism Presets

Molecular Kinetics Controls

Particle Dosing / Load: 50

Ribosome Efficiency: 85%

MHC-I Processing Speed: 90%

Simulation Timeline Scrub: 0.0s

Live Kinetic Telemetry

Cell Viability

98.5%

Translated Antigens

120

MHC-I Presentations

Neutralizing Titer

850

Molecular Status & Evidence

Baseline Active: mRNA LNP delivery active. Ribosomal machinery synthesizing non-infectious target antigens. Viability high at 98.5%.